pCMV-Neo-Bam APC 1-1941 Citations (3)

Originally described in: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW Science. 1997 Mar 21. 275(5307):1787-90. PubMed Journal

---

Articles Citing pCMV-Neo-Bam APC 1-1941

Articles
Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction. Ahn SY, Kim NH, Lee K, Cha YH, Yang JH, Cha SY, Cho ES, Lee Y, Cha JS, Cho HS, Jeon Y, Yuk YS, Cho S, No KT, Kim HS, Lee H, Choi J, Yook JI. Oncotarget. 2017 May 9;8(19):31842-31855. doi: 10.18632/oncotarget.16252. PubMed
Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer. Kang HE, Seo Y, Yun JS, Song SH, Han D, Cho ES, Cho SB, Jeon Y, Lee H, Kim HS, Kang J, Yook JI, Kim NH, Kim TI. Cancers (Basel). 2021 Jul 9;13(14). pii: cancers13143437. doi: 10.3390/cancers13143437. PubMed
Predicting Agents That Can Overcome 5-FU Resistance in Colorectal Cancers via Pharmacogenomic Analysis. Huang TC, Peng KC, Kuo TT, Lin LC, Liu BC, Ye SP, Chu CC, Hsia SM, Chang HY. Biomedicines. 2021 Jul 24;9(8). pii: biomedicines9080882. doi: 10.3390/biomedicines9080882. PubMed

If you have published an article using this material, please email us at to have your article added to this page.